Peter G. Edwards - 08 Sep 2022 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Sep 2022, 17:09:20 UTC
Prior SEC filing
10 Mar 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jeffrey Hamet, Attorney-in-Fact for Peter G. Edwards

Key filing fact

Peter G. Edwards filed Form 4 for AZIYO BIOLOGICS, INC. (ELUT) on 12 Sep 2022.

Key facts

  • This page summarizes Peter G. Edwards's Form 4 filing for AZIYO BIOLOGICS, INC. (ELUT).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 12 Sep 2022, 17:09.

Change

  • Previous filing in this sequence was filed on 10 Mar 2022.
  • Current net transaction value: -$8,227.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AZYO transaction

Class A Common Stock

Options Exercise

Transaction value
Shares
+4,625
Change %
Price
Shares after
4,625
Date
08 Sep 2022
Ownership
Direct
Footnotes
F1
AZYO transaction

Class A Common Stock

Tax liability

Transaction value
$8,227
Shares
-1,127
Change %
-24%
Price
$7.30*
Shares after
3,498
Date
08 Sep 2022
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AZYO transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-4,625
Change %
-100%
Price
$0.000000*
Shares after
0
Date
08 Sep 2022
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
4,625
Exercise price
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.

Footnote F2

Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.

Footnote F3

The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .